Literature DB >> 28550488

The Value of Preoperative Positron Emission Tomography/Computed Tomography in Node-Negative Endometrial Cancer on Magnetic Resonance Imaging.

Jeong-Yeol Park1, Jong Jin Lee2, Hyuck Jae Choi3, In Hye Song4, Chang Ohk Sung4, Hye Ok Kim2, Sun-Young Chae2, Young-Tak Kim5, Joo-Hyun Nam5.   

Abstract

OBJECTIVE: The aim of this study was to investigate the value of [18F]fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in predicting lymph node status in node-negative endometrial cancer on preoperative magnetic resonance imaging (MRI).
METHODS: Patients with endometrial cancer who underwent both preoperative MRI and FDG-PET/CT followed by hysterectomy and lymphadenectomy were initially included. We then enrolled patients with MRI-defined node-negative disease (lymph nodes <1 cm in the short-axis diameter, or no visible lymph node). Histologic examination was the gold standard for lymph node metastasis diagnosis. The diagnostic performance of FDG-PET/CT in predicting lymph node metastasis was calculated in patient-by-patient and lymph node station-by-station analyses.
RESULTS: On preoperative MRI, 362 patients had no lymph node metastasis. All patients underwent pelvic lymph node dissection and 118 patients underwent further para-aortic lymph node dissection. From 2099 lymph node stations, 10,238 lymph nodes were retrieved. Twenty-seven patients (7.5%) had lymph node metastasis in 49 lymph node stations (2.3%) on pathologic examination. FDG-PET/CT identified lymph node metastasis in five patients (18.5%) and eight lymph node stations (16.3%). The median diameter of false-negative metastatic lymph nodes was 6 mm (range 1-22) in the long axis and 3 mm (range 1-11) in the short axis. For para-aortic lymph nodes, FDG-PET/CT diagnosed 2 of 11 patients (18.1%) with para-aortic lymph node metastasis, and 3 of 12 para-aortic lymph node stations (25%) with metastasis.
CONCLUSION: Preoperative FDG-PET/CT has low value in predicting lymph node metastasis in node-negative endometrial cancer on preoperative MRI.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28550488     DOI: 10.1245/s10434-017-5901-8

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  7 in total

1.  Comments on: Fertility-sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: a Gynecologic Cancer Inter-Group (GCIG) study.

Authors:  Jeong Yeol Park
Journal:  J Gynecol Oncol       Date:  2020-11       Impact factor: 4.401

2.  ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.

Authors:  Nicole Concin; Carien L Creutzberg; Ignace Vergote; David Cibula; Mansoor Raza Mirza; Simone Marnitz; Jonathan A Ledermann; Tjalling Bosse; Cyrus Chargari; Anna Fagotti; Christina Fotopoulou; Antonio González-Martín; Sigurd F Lax; Domenica Lorusso; Christian Marth; Philippe Morice; Remi A Nout; Dearbhaile E O'Donnell; Denis Querleu; Maria Rosaria Raspollini; Jalid Sehouli; Alina E Sturdza; Alexandra Taylor; Anneke M Westermann; Pauline Wimberger; Nicoletta Colombo; François Planchamp; Xavier Matias-Guiu
Journal:  Virchows Arch       Date:  2021-02       Impact factor: 4.064

Review 3.  Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology.

Authors:  Stephanie Nougaret; Mariana Horta; Evis Sala; Yulia Lakhman; Isabelle Thomassin-Naggara; Aki Kido; Gabriele Masselli; Nishat Bharwani; Elizabeth Sadowski; Andrea Ertmer; Milagros Otero-Garcia; Rahel A Kubik-Huch; Teresa M Cunha; Andrea Rockall; Rosemarie Forstner
Journal:  Eur Radiol       Date:  2018-07-11       Impact factor: 5.315

4.  Noninvasive CT radiomic model for preoperative prediction of lymph node metastasis in early cervical carcinoma.

Authors:  Jiaming Chen; Bingxi He; Di Dong; Ping Liu; Hui Duan; Weili Li; Pengfei Li; Lu Wang; Huijian Fan; Siwen Wang; Liwen Zhang; Jie Tian; Zhipei Huang; Chunlin Chen
Journal:  Br J Radiol       Date:  2020-01-30       Impact factor: 3.039

5.  The diagnostic accuracy of fluorodeoxyglucose-positron emission tomography/computed tomography and sentinel node biopsy in the prediction of pelvic lymph node metastasis in patients with endometrial cancer: A retrospective observational study.

Authors:  Tomohito Tanaka; Yoshito Terai; Kazuhiro Yamamoto; Takashi Yamada; Masahide Ohmichi
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

Review 6.  Characterizing and quantifying low-value diagnostic imaging internationally: a scoping review.

Authors:  Elin Kjelle; Eivind Richter Andersen; Arne Magnus Krokeide; Lesley J J Soril; Leti van Bodegom-Vos; Fiona M Clement; Bjørn Morten Hofmann
Journal:  BMC Med Imaging       Date:  2022-04-21       Impact factor: 2.795

7.  Endometrial cancer-how many patients could benefit from sentinel lymph node dissection?

Authors:  Sarah Brugger; Moritz Hamann; Marc Mosner; Michaela Beer; Michael Braun; Martin Pölcher
Journal:  World J Surg Oncol       Date:  2018-05-17       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.